Skip to content
Catalyst

Emblica officinalisFinding

Emblica officinalis decreases total cholesterol (TC)

lowersModerate evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“The reduction in TC was highly significant (p = 0.0003) between amla extract and placebo group.”
Quoted verbatim from A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia.
This finding among the 116 findings on its endpoint

Emblica officinalis

Total cholesterol (TC)

lowers

Who
Adults aged 30 to 65 with dyslipidemia (TG > 200, LDL-C > 130, TC > 200 mg/dL, low HDL-C), 49 per arm, off lipid-lowering medication for 4 weeks; all patients also asked to start a healthy diet and exercise in both arms; fasting samples at 12 weeks
Dose studied
500 mg capsule twice daily, after breakfast and after dinner, for 12 weeks

Moderate evidencePMID 30670010 · 2019

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

BMC complementary and alternative medicine
What else it reported1 finding · 0 compounds · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7060Y2HDDTRESXTBBE9BBQ2